206 related articles for article (PubMed ID: 31267413)
1. Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.
Stingl K; Kurtenbach A; Hahn G; Kernstock C; Hipp S; Zobor D; Kohl S; Bonnet C; Mohand-Saïd S; Audo I; Fakin A; Hawlina M; Testa F; Simonelli F; Petit C; Sahel JA; Zrenner E
Doc Ophthalmol; 2019 Oct; 139(2):151-160. PubMed ID: 31267413
[TBL] [Abstract][Full Text] [Related]
2. CLINICAL PRESENTATION AND DISEASE COURSE OF USHER SYNDROME BECAUSE OF MUTATIONS IN MYO7A OR USH2A.
Testa F; Melillo P; Bonnet C; Marcelli V; de Benedictis A; Colucci R; Gallo B; Kurtenbach A; Rossi S; Marciano E; Auricchio A; Petit C; Zrenner E; Simonelli F
Retina; 2017 Aug; 37(8):1581-1590. PubMed ID: 27828912
[TBL] [Abstract][Full Text] [Related]
3. Usher Syndrome and Color Vision.
Kurtenbach A; Hahn G; Kernstock C; Hipp S; Zobor D; Stingl K; Kohl S; Bonnet C; Mohand-Saïd S; Sliesoraityte I; Sahel JA; Audo I; Fakin A; Hawlina M; Testa F; Simonelli F; Petit C; Zrenner E
Curr Eye Res; 2018 Oct; 43(10):1295-1301. PubMed ID: 30012035
[TBL] [Abstract][Full Text] [Related]
4. Cone responses in Usher syndrome types 1 and 2 by microvolt electroretinography.
Zein WM; Falsini B; Tsilou ET; Turriff AE; Schultz JM; Friedman TB; Brewer CC; Zalewski CK; King KA; Muskett JA; Rehman AU; Morell RJ; Griffith AJ; Sieving PA
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):107-14. PubMed ID: 25425308
[TBL] [Abstract][Full Text] [Related]
5. The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.
Birch DG; Cheng P; Duncan JL; Ayala AR; Maguire MG; Audo I; Cheetham JK; Durham TA; Fahim AT; Ferris FL; Heon E; Huckfeldt RM; Iannaccone A; Khan NW; Lad EM; Michaelides M; Pennesi ME; Stingl K; Vincent A; Weng CY;
Transl Vis Sci Technol; 2020 Oct; 9(11):9. PubMed ID: 33133772
[TBL] [Abstract][Full Text] [Related]
6. Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
Duncan JL; Liang W; Maguire MG; Audo I; Ayala AR; Birch DG; Carroll J; Cheetham JK; Esposti SD; Durham TA; Erker L; Farsiu S; Ferris FL; Heon E; Hufnagel RB; Iannaccone A; Jaffe GJ; Kay CN; Michaelides M; Pennesi ME; Sahel JA;
Am J Ophthalmol; 2020 Nov; 219():87-100. PubMed ID: 32446738
[TBL] [Abstract][Full Text] [Related]
7. Unanticipated prognosis for a patient with type 2 Usher syndrome.
Vezinaw CM; Fishman GA; Chiang J
Doc Ophthalmol; 2019 Apr; 138(2):161-166. PubMed ID: 30796641
[TBL] [Abstract][Full Text] [Related]
8. Central Retina Functional Damage in Usher Syndrome Type 2: 22 Years of Focal Macular ERG Analysis in a Patient Population From Central and Southern Italy.
Galli-Resta L; Placidi G; Campagna F; Ziccardi L; Piccardi M; Minnella A; Abed E; Iovine S; Maltese P; Bertelli M; Falsini B
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3827-3835. PubMed ID: 30073356
[TBL] [Abstract][Full Text] [Related]
9. [Visual acuity and full-field electroretinography in patients with Usher's syndrome].
Mendieta L; Berezovsky A; Salomão SR; Sacai PY; Pereira JM; Fantini SC
Arq Bras Oftalmol; 2005; 68(2):171-6. PubMed ID: 15905936
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
[TBL] [Abstract][Full Text] [Related]
11. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.
Messias K; Jägle H; Saran R; Ruppert AD; Siqueira R; Jorge R; Messias A
Doc Ophthalmol; 2013 Oct; 127(2):123-9. PubMed ID: 23733195
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes in defined genotypes including siblings with Usher syndrome.
Malm E; Ponjavic V; Möller C; Kimberling WJ; Andréasson S
Ophthalmic Genet; 2011 Jun; 32(2):65-74. PubMed ID: 21174530
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
Mustafic N; Ristoldo F; Nguyen V; Fraser CL; Invernizzi A; Jamieson RV; Grigg JR
Doc Ophthalmol; 2020 Dec; 141(3):205-215. PubMed ID: 32240425
[TBL] [Abstract][Full Text] [Related]
14. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
15. Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2.
Fakin A; Jarc-Vidmar M; Glavač D; Bonnet C; Petit C; Hawlina M
Vision Res; 2012 Dec; 75():60-70. PubMed ID: 23000274
[TBL] [Abstract][Full Text] [Related]
16. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
17. Current updates on genetic spectrum of usher syndrome.
Ullah F; Zeeshan Ali M; Ahmad S; Muzammal M; Khan S; Khan J; Ahmad Khan M
Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-24. PubMed ID: 38718411
[TBL] [Abstract][Full Text] [Related]
18. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
Kaiserman N; Obolensky A; Banin E; Sharon D
Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
[TBL] [Abstract][Full Text] [Related]
19. Relationship between difficulty in performing daily activities and clinical measures of visual function in patients with retinitis pigmentosa.
Szlyk JP; Fishman GA; Alexander KR; Revelins BI; Derlacki DJ; Anderson RJ
Arch Ophthalmol; 1997 Jan; 115(1):53-9. PubMed ID: 9006425
[TBL] [Abstract][Full Text] [Related]
20. Evidence for impaired olfactory function and structural brain integrity in a disorder of ciliary function, Usher syndrome.
Ramos JN; Ribeiro JC; Pereira AC; Ferreira S; Duarte IC; Castelo-Branco M
Neuroimage Clin; 2019; 22():101757. PubMed ID: 30897432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
